Grants and Contributions:

Back to search
Agreement Number:
-
Agreement Value:
$105,000.00
Agreement Date:
May 1, 2016 - Apr 30, 2019
Description:
Positive Allosteric Modulators of Metabotropic Glutamate Receptor 5 as Novel Therapeutics for Schizophrenia: Determining the Mechanisms of Action Underlying Cognition-enhancing and Antipsychotic-like Effects
Organization:
Canadian Institutes of Health Research
Location:
Nashville, US
Reference Number:
236-2016-2017-Q1-00254
Agreement Type:
Grant
Report Type:
Grants and Contributions
Additional Information:

Grant or Award spanning more than one fiscal year.
(2016-17 to 2019-20)

Start date may be subject to change. Funding for awards must commence within 12 months of the date of offer.

Recipient's Legal Name:
Maksymetz, James
Research Organization:
Vanderbilt University (Tennessee)